Neal C. Bradsher, 10% Owner at OncoCyte Corp (OCX), bought 2,352,942 shares at $1.70 ($4.0M) on 2019-11-13, disclosed to the SEC on 2019-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.70 | 1,176,471 | $2.0M | 50.0% |
| 2 | $1.70 | 1,176,471 | $2.0M | 50.0% |
| Total | $1.70 avg | 2,352,942 | $4.0M | 100% |
| Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-11-21 | $82.1M | — | Filing → |
| STAA | BUY | 2025-04-10 | $5.4M | — | Filing → |